Want to continue the discussion? Send me a message.

“I feel amazing” is usually what we hope to hear after months of depression. With bipolar depression, it can also be the moment we need to slow down and get much more precise about what “better” actually means.

We start Part 1 of our Bipolar Depression in Practice series with a deceptively hard clinical question: how do we tell the difference between recovery toward euthymia and a slide into hypomania or mania? I walk through a case that changed how I listen, especially when a client knows the language of mental health but does not recognize elevated mood in their own life. From there, we get practical and specific, because broad questions often miss the signal.

We dig into the assessment details that matter most: energy that returns to baseline versus energy that overshoots, productivity that fits a normal range versus productivity that feels endless, and spending changes that only make sense when you know the client’s usual pattern. Sleep gets its own deep dive, because “I slept four hours” can describe insomnia with exhaustion or decreased need for sleep with sustained function, and those are not the same clinical story. We also talk about why “baseline” is personal, how long depression can reset a client’s reference point, and how collateral input from family or partners can add context without automatically defining the client’s reality.

Want to continue the discussion? Send me a message.

We wait for a relapse, a missed stretch of pills, or a hospitalization, and only then the words “long-acting injectable” finally show up. I’m stepping back to ask a cleaner question for bipolar I disorder care: what needs to be true before an LAI earns a place in the conversation, not as a last resort, but as a thoughtfully explained option in maintenance treatment.

I walk through the difference between mentioning LAIs, considering them, and recommending them, because those are not the same moment clinically. We talk about why I introduce the option when a patient is stable and thriving on an oral medication, how psychoeducation reduces pressure, and why I don’t want anyone learning about injections for the first time during a crisis. From there, we get into a hard truth about mania: insight can drop while symptoms rise, and what feels “normal” internally can look dangerous externally. That distinction matters for relapse prevention planning and shared decision-making.

I also share what sticks with me after episodes end: patients may be clinically better but still recouping their lives, relationships, work, and public digital footprints. Finally, I unpack a case that exposes a common misunderstanding, when a patient assumes the injection replaces the rest of the treatment plan and quietly stops a key medication.

Want to continue the discussion? Send me a message.

A patient says, “I hate needles,” and the room tightens. Do we hear a hard no, a fear we can work with, or a past experience that needs words before it needs a plan? We get real about long-acting injectable antipsychotics (LAIs) and what the conversation actually sounds like in everyday psychiatric care when I’m excited about an option and my client is unsure.

We dig into motivational interviewing skills that matter in the moment: reflective listening, strategic silence, and affirmations that don’t feel like pressure. I walk through “elicit, provide, elicit” in plain language so we can share why an LAI might help (daily adherence struggles, breakthrough symptoms, clearer monitoring) and then give the decision right back to the person in front of us. We also name the uncomfortable truth that clinician comfort and uncertainty can shape how we present choices, sometimes making an injection sound like a last resort even when it isn’t.

“I need to think about it” gets treated with respect and structure, including what to do when clients Google medications, land on Reddit horror stories, or worry about side effects and long duration in the body. We talk about building a realistic follow-up plan, keeping the door open without standing in the doorway, and what changes when an LAI already has a history from hospitalization. By the end, success isn’t a yes to the injection, it’s clarity: do we understand the concern, the meaning, and what happens next?